Etanercept and Vascular Function in Psoriasis
clinical trial
Press Enter · cited answer in seconds
0 sources
Etanercept and Vascular Function in Psoriasis
Summary
Etanercept and Vascular Function in Psoriasis is a clinical trial[1].
Key Facts
- Etanercept and Vascular Function in Psoriasis is in the country of United States[2].
- Etanercept and Vascular Function in Psoriasis's instance of is recorded as clinical trial[3].
- Etanercept and Vascular Function in Psoriasis's start time is recorded as +2010-08-31T00:00:00Z[4].
- Etanercept and Vascular Function in Psoriasis's end time is recorded as +2013-09-30T00:00:00Z[5].
- Etanercept and Vascular Function in Psoriasis's main subject is recorded as psoriasis[6].
- Etanercept and Vascular Function in Psoriasis's number of participants is recorded as {'unit': '1', 'amount': '+24'}[7].
- Etanercept and Vascular Function in Psoriasis's title is recorded as Etanercept and Vascular Function in Psoriasis[8].
- Etanercept and Vascular Function in Psoriasis's short name is recorded as EVIP[9].
- Etanercept and Vascular Function in Psoriasis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}[10].
- Etanercept and Vascular Function in Psoriasis's ClinicalTrials.gov ID is recorded as NCT01989689[11].
- Etanercept and Vascular Function in Psoriasis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}[12].
- Etanercept and Vascular Function in Psoriasis's research intervention is recorded as etanercept[13].
- Etanercept and Vascular Function in Psoriasis's clinical trial phase is recorded as phase II clinical trial[14].
- Etanercept and Vascular Function in Psoriasis's research site is recorded as Emory University[15].
- Etanercept and Vascular Function in Psoriasis's research subject recruitment status is recorded as completed[16].
- Etanercept and Vascular Function in Psoriasis's study type is recorded as interventional study[17].